# Hôpital Dupuytren

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hopital-dupuytren/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 40 |
| Citations | 306,150 |
| City | Draveil |
| Country | FR |
| Description | Hôpital Dupuytren is a research organisation in Draveil, FR. OpenAlex records 6,178 works and 306,150 citations for it. 1,587 researchers list it as their most recent affiliation. |
| Homepage | http://chu-mondor.aphp.fr/joffredupuytren/ |
| OpenAlex ID | https://openalex.org/I4210159361 |
| Researchers | 1,587 |
| ROR ID | https://ror.org/053385a79 |
| Type | healthcare |
| Works | 6,178 |

## University papers

- [Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial](https://scholariq.org/papers/erlotinib-versus-standard-chemotherapy-as-first-line-treatment-for-european/)
- [Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-plus-ipilimumab-in-advanced-non-small-cell-lung-cancer/)
- [Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC](https://scholariq.org/papers/atezolizumab-for-first-line-treatment-of-pd-l1-selected-patients-with-nsclc/)
- [First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial](https://scholariq.org/papers/first-line-nivolumab-plus-ipilimumab-in-advanced-nsclc-4-year-outcomes-from-the/)

## University top topics

Showing 8 of 25.

- [Health, Medicine and Society](https://scholariq.org/topics/health-medicine-and-society/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Aging, Elder Care, and Social Issues](https://scholariq.org/topics/aging-elder-care-and-social-issues/)
- [Healthcare Systems and Practices](https://scholariq.org/topics/healthcare-systems-and-practices/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.